Oyster Point Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Oyster Point Pharma generated cash of -$89,370,000, which is less than the previous year. Cash used in financing activities reached the amount of $91,642,000 last year. Net change in cash is therefore $787,000.
Cash Flow
| 2017 | -4.67M | 0 | 26.17M |
|---|---|---|---|
| 2018 | -17.08M | 0 | 0 |
| 2019 | -40.81M | -200K | 174.98M |
| 2020 | -58.39M | -700K | 112.54M |
| 2021 | -89.37M | -1.48M | 91.64M |
OYST Cash Flow Statement (2017 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
Cash at beginning of period | 192.64M | 139.19M | 5.22M | 22.31M | 810K |
Operating activities | |||||
Net income | -100.65M | -70.52M | -45.71M | -16.50M | -6.60M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 141K | 461K | 19K | 0 | 0 |
Stock-based compensation expense | 11.94M | 6.97M | 3.26M | 154K | 119K |
| Deferred income tax benefit | 11.94M | 6.97M | 3.26M | 154K | 119K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -6.65M | 0 | 0 | 0 | 0 |
Inventories | -6.96M | 0 | 0 | 0 | 0 |
Accounts payable | 3.86M | 1.77M | 38K | 44K | 61K |
Cash generated by operating activities | -89.37M | -58.39M | -40.81M | -17.08M | -4.67M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.48M | -700K | -200K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.48M | -700K | -200K | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 0 | 112.90M | 82.13M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 91.64M | 112.54M | 174.98M | 0 | 26.17M |
Net Change In Cash | 787K | 53.44M | 133.97M | -17.08M | 21.50M |
Cash at end of period | 193.43M | 192.64M | 139.19M | 5.22M | 22.31M |
| Data source | Data source | Data source |